Goldman Sachs Boosts BioNTech Outlook: New Buy Rating Sparks Interest
On November 8, 2024, Goldman Sachs upgraded their outlook for BioNTech SE – Depositary Receipt (WBAG:BNTX) from Neutral to Buy.
Current Fund Sentiment on BioNTech
There are 396 funds and institutions currently reporting positions in BioNTech SE – Depositary Receipt, marking an increase of one owner, or 0.25%, over the last quarter. The average portfolio weight across all funds dedicated to BNTX stands at 0.27%, showing a 9.20% rise. However, total shares owned by institutions decreased by 3.33% over the past three months, now totaling 47,671K shares.
Baillie Gifford holds 8,308K shares. In its previous filing, the firm reported 8,276K shares, indicating an increase of 0.38%. However, Baillie Gifford decreased its portfolio allocation in BNTX by 46.42% in the last quarter.
Primecap Management reports ownership of 4,517K shares, down from 4,790K shares, representing a decrease of 6.04%. Conversely, the firm’s portfolio allocation in BNTX increased by 41.54% during the same period.
Flossbach Von Storch holds 4,360K shares, slightly down from 4,379K shares, reflecting a decrease of 0.46%. Notably, Flossbach Von Storch raised its portfolio allocation in BNTX by 37.66% over the last quarter.
Harding Loevner now holds 2,927K shares, a decline from 3,818K shares, which is a decrease of 30.46%. The firm also cut its portfolio allocation in BNTX by 40.28% in the last quarter.
The VHCOX – Vanguard Capital Opportunity Fund Investor Shares reports ownership of 2,372K shares, an increase of 0.65% from 2,357K shares. However, the firm reduced its portfolio allocation in BNTX by 14.07% during this time.
Fintel serves as a vital resource for investors, traders, financial advisors, and small hedge funds, offering a wide range of investment research tools.
Its platform provides insights into fundamentals, analyst reports, ownership data, fund sentiment, insider trading, and more. Exclusive stock picks are also available, powered by advanced, backtested quantitative models designed to enhance profits.
Click to Learn More
This story originally appeared on Fintel.
The views and opinions expressed herein are those of the author and do not necessarily reflect those of Nasdaq, Inc.
